/AI%20(artificial%20intelligence)/Hands%20of%20robot%20and%20human%20touching%20on%20big%20data%20network%20connection%20by%20PopTika%20via%20Shutterstock.jpg)
Recursion Pharmaceuticals (RXRX) shares closed up 27% after the Food and Drug Administration (FDA) said it wants to phase out animal testing in drug development.
The U.S. regulatory authority wants to switch to “more effective, human-relevant methods” instead, including machine learning and artificial intelligence, according to its press release on Friday.